Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinoma-Reference-Cited by-同舟云学术

Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinoma

Published:2023-06 Issue: Volume:563 Page:216192
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Yang Shih-Feng^ORCID,Weng Meng-Tzu,Liang Ja-Der,Chiou Ling-Ling,Hsu Yu-Chen,Lee Ying-Te,Liu Shin-Yun,Wu Meng-Chuan,Chou Huei-Chi,Wang Li-Fang,Yu Shu-Han,Lee Hsuan-Shu^ORCID,Sheu Jin-Chuan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference72 articles.

1. Hepatocellular carcinoma;El-Serag;N. Engl. J. Med.,2011

2. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008

4. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol.,2009

5. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial;Kudo;Lancet,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revamping Hepatocellular Carcinoma Immunotherapy: The Advent of Microbial Neoantigen Vaccines;Vaccines;2024-08-21

2. Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment;Advanced Therapeutics;2024-07-06

3. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives;Journal of Hematology & Oncology;2024-04-29

4. Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways;Hepatoma Research;2024-04-26

5. B7–H1 agonists suppress the PI3K/AKT/mtor pathway by degrading p110γ and independently induce cell death;Cancer Letters;2024-03